This is a supplement to BLES Biochemicals Inc. (A), product 9B03M026. The (A) case explores the growth options available to a new biotech company with a revolutionary drug for premature infants. There seems to be a significant potential for international growth. The (B) case takes place six months later when the president of the company obtains new data concerning market size projections, technological advances and competitor actions that require him to reconsider the company's strategic positioning and plans for international expansion.
看看哪些人也有訂購？